← 產業報告目錄

Oxygen Concentrators Market by Type (Portable, Stationary), Technology (Continuous and Pulse Flow), Flowrate (0-5L/Min, 5-10L/Min, Above 10L/Min), Application (Chronic Obstructive Pulmonary Disorder), End User (Home Care Settings) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-09-04頁數 246報告編號 MD9480

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The oxygen concentrators market is projected to reach USD 1.71 billion by 2030 from USD 1.27 billion in 2025, at a CAGR of 6.1% during the forecast period. Technological advancements are crucial in driving growth in the oxygen concentrators market. Modern units are more compact, lightweight, energy-efficient, and user-friendly. Innovations like pulse dose technology deliver oxygen only during inhalation to conserve it and extend battery life, especially in portable models. New devices feature silent operation, digital displays, alarms, connectivity for remote monitoring, and support both pulse and continuous flow modes. Portable concentrators with long-lasting batteries are popular among active users and travelers, some FAA-approved for flights. IoT integration enables real-time data sharing with healthcare providers, enhancing patient compliance. AI algorithms optimize oxygen delivery based on respiratory patterns. These innovations improve convenience, patient quality of life, and broaden application scope, fueling market growth as adoption increases. Based on type, the market is divided into portable and stationary oxygen concentrators. In 2024, the portable oxygen concentrator segment holds the largest share of the global oxygen concentrator market. The increasing global geriatric population is a key factor driving demand for portable oxygen concentrators (POCs). Older adults are more vulnerable to chronic respiratory conditions such as COPD, pulmonary fibrosis, and hypoxia related to heart failure. Mobility challenges in old age make POCs a practical solution, allowing elderly patients to receive oxygen therapy without being restricted to a stationary device. Being able to carry oxygen support while moving around at home, outdoors, or during travel greatly improves their independence and quality of life. As the aging population continues to grow—especially in developed areas like North America, Europe, and parts of Asia—the demand for compact, dependable, and easy-to-use oxygen devices like POCs steadily increases, strengthening their market dominance. Based on end users, the OC market has been categorized into home care settings, hospitals and clinics, and ambulatory surgical centers & physician offices. In 2024, home care settings held the largest share in the OC market. The increasing global elderly population is a key factor driving demand in the home care segment of the oxygen concentrators market. Older adults are more vulnerable to chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), emphysema, and age-related decline in lung function. These conditions often require long-term oxygen therapy, which is increasingly managed at home due to its convenience and lower cost. Additionally, elderly patients often face mobility issues, making frequent hospital visits difficult. Home-based oxygen concentrators provide a safe and accessible solution, allowing independence while maintaining continuous respiratory support. Countries like Japan, Germany, Italy, and the US—with rapidly aging populations—are seeing a particularly high adoption of oxygen concentrators in home care settings. North America is expected to hold the largest share of the OC market during the forecast period. North America, especially the US and Canada, has highly developed healthcare systems equipped with modern diagnostic and therapeutic technologies. The region's hospitals, clinics, and outpatient centers have widespread access to oxygen delivery equipment, including concentrators. Additionally, structured healthcare policies, integrated insurance networks, and streamlined procurement channels ensure the smooth availability and distribution of these devices. Patients benefit from faster diagnoses and prompt initiation of oxygen therapy. Home care support systems are also advanced, allowing a safe transition from hospital to home with continuous oxygen support. These favorable conditions improve the accessibility and use of oxygen concentrators, especially for chronic patients, and reinforce North America's leadership position in the global oxygen concentrators market. A breakdown of the primary participants (supply-side) for the oxygen concentrators market referred to in this report is provided below: • By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28% • By Designation: C-level: 26%, Director Level: 35%, and Others: 39% • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5% Major players in the oxygen concentrators market include Koninklijke Philips N.V. (Netherlands), Inogen, Inc. (US), Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (China), Caire, Inc. (US), and Drive DeVilbiss Healthcare (US).   Research Coverage The report assesses the oxygen concentrators market and estimates its size and future growth potential across various segments, including type, technology, flow rate, application, end user, and region. It also provides a competitive analysis of the leading companies in the market, along with their profiles, product offerings, recent developments, and key strategies. Reasons to Buy the Report The report will help market leaders and new entrants by providing data on the closest estimates of revenue for the overall oxygen concentrators market and its subsegments. It will aid stakeholders in understanding the competitive landscape and gaining insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp market trends and offers data on key drivers, obstacles, challenges, and opportunities within the market. This report provides insights into the following points:  Analysis of key drivers (rising prevalence of respiratory diseases, growing geriatric population, increasing demand for home healthcare, government initiatives and reimbursement support, technological advancements), restraints (high cost of advanced oxygen concentrators, product recalls or malfunctions), opportunities (integration of digital health features, development of solar-powered or battery-efficient models) and challenges (lack of awareness and diagnosis, competition from low-cost alternatives) • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global OC market • Market Development: Thorough knowledge and analysis of the profitable rising markets by type, technology, flowrate, application, end user, and region • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global OC market • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global OC market
目錄 Table of Contents
1 INTRODUCTION 24 1.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.2.1 INCLUSIONS AND EXCLUSIONS 25 1.3 STUDY SCOPE 26 1.3.1 SEGMENTS COVERED 26 1.4 YEARS CONSIDERED 27 1.5 CURRENCY USED 27 1.6 STAKEHOLDERS 28 1.7 LIMITATIONS 28 2 RESEARCH METHODOLOGY 29 2.1 RESEARCH DATA 29 2.1.1 SECONDARY DATA 29 2.1.1.1 Key data from secondary sources 31 2.1.2 PRIMARY DATA 31 2.1.2.1 Key data from primary sources 32 2.1.2.2 Key industry insights 33 2.2 MARKET SIZE ESTIMATION 35 2.3 DATA TRIANGULATION 41 2.4 MARKET SHARE ESTIMATION 42 2.5 STUDY ASSUMPTIONS 42 2.6 METHODOLOGY-RELATED LIMITATIONS 42 2.7 RISK ASSESSMENT 43 3 EXECUTIVE SUMMARY 44 4 PREMIUM INSIGHTS 48 4.1 OXYGEN CONCENTRATORS MARKET OVERVIEW 48 4.2 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY AND COUNTRY 49 4.3 OXYGEN CONCENTRATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 50 4.4 OXYGEN CONCENTRATORS MARKET, REGIONAL MIX 50 4.5 OXYGEN CONCENTRATORS MARKET: EMERGING VS. DEVELOPED MARKETS 51 5 MARKET OVERVIEW 52 5.1 INTRODUCTION 52 5.2 MARKET DYNAMICS 52 5.2.1 DRIVERS 53 5.2.1.1 Growing prevalence of chronic respiratory diseases 53 5.2.1.2 Preference for home-based oxygen therapy 54 5.2.1.3 Technological advancements in portable oxygen concentrators 54 5.2.2 RESTRAINTS 55 5.2.2.1 High initial cost and limited reimbursement in some markets 55 5.2.3 OPPORTUNITIES 55 5.2.3.1 Expansion in emerging markets 55 5.2.3.2 Integration with remote monitoring and telehealth 56 5.2.3.3 Institutional demand and tender-based opportunities 56 5.2.4 CHALLENGES 57 5.2.4.1 Operational limitations in remote and power-constrained areas 57 5.2.4.2 Quality variability and regulatory compliance challenges 57 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58 5.4 PRICING ANALYSIS 59 5.4.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE 59 5.4.2 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS, BY REGION 60 5.5 VALUE CHAIN ANALYSIS 61 5.6 SUPPLY CHAIN ANALYSIS 62 5.7 ECOSYSTEM ANALYSIS 64 5.8 INVESTMENT & FUNDING SCENARIO 65 5.9 TECHNOLOGY ANALYSIS 67 5.9.1 KEY TECHNOLOGIES 67 5.9.1.1 Pressure swing adsorption (PSA) technology 67 5.9.1.2 Pulse-dose vs. continuous flow delivery 67 5.9.2 COMPLEMENTARY TECHNOLOGIES 68 5.9.2.1 Remote patient monitoring (RPM) integration 68 5.9.2.2 Battery and power management systems 68 5.9.3 ADJACENT TECHNOLOGIES 68 5.9.3.1 PSA oxygen plants 68 5.9.3.2 Oxygen cylinders as backup systems 68 5.10 INDUSTRY TRENDS 69 5.10.1 RISING DEMAND FOR HOME-BASED OXYGEN THERAPY 69 5.10.2 INTEGRATION WITH TELEHEALTH AND REMOTE MONITORING 69 5.10.3 SHIFT TOWARD PORTABLE AND WEARABLE TECHNOLOGIES 69 5.10.4 CONSOLIDATION AND COMPETITIVE LANDSCAPE EVOLUTION 69 5.11 PATENT ANALYSIS 70 5.12 TRADE ANALYSIS 71 5.12.1 IMPORT DATA (HS CODE 901920) 71 5.12.2 EXPORT DATA (HS CODE 901920) 72 5.13 KEY CONFERENCES & EVENTS, 2025–2026 73 5.14 CASE STUDY ANALYSIS 74 5.14.1 DEPLOYMENT OF PORTABLE OXYGEN CONCENTRATORS IN RURAL INDIA 74 5.14.2 INOGEN’S DIRECT-TO-CONSUMER EXPANSION IN US 74 5.14.3 BELLUSCURA’S STRATEGIC PARTNERSHIP WITH CHINESE OEM 74 5.15 REGULATORY ANALYSIS 75 5.16 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 5.16.1 REGULATORY LANDSCAPE 76 5.16.1.1 North America 76 5.16.1.1.1 US 77 5.16.1.1.2 Canada 77 5.16.1.2 Europe 77 5.16.1.2.1 Germany 77 5.16.1.2.2 France 77 5.16.1.2.3 UK 78 5.16.1.3 Asia Pacific 78 5.16.1.3.1 China 78 5.16.1.3.2 Japan 79 5.16.1.3.3 India 79 5.16.1.4 Latin America 79 5.16.1.4.1 Brazil 79 5.16.1.4.2 Mexico 80 5.16.1.5 Middle East & Africa 80 5.16.1.5.1 South Africa 80 5.16.1.5.2 GCC Countries 80 5.17 PORTER’S FIVE FORCES ANALYSIS 81 5.17.1 THREAT OF NEW ENTRANTS 82 5.17.2 THREAT OF SUBSTITUTES 82 5.17.3 BARGAINING POWER OF SUPPLIERS 82 5.17.4 BARGAINING POWER OF BUYERS 82 5.17.5 INTENSITY OF COMPETITIVE RIVALRY 83 5.18 KEY STAKEHOLDERS & BUYING CRITERIA 83 5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS 83 5.18.2 BUYING CRITERIA 84 5.19 UNMET NEEDS/END-USER EXPECTATIONS 85 5.20 IMPACT OF 2025 US TARIFF ON OXYGEN CONCENTRATORS MARKET 85 5.20.1 KEY TARIFF RATES 86 5.20.2 PRICE IMPACT ANALYSIS 87 5.20.3 KEY IMPACT ON COUNTRY/REGION 87 5.20.3.1 US 87 5.20.3.2 Europe 87 5.20.3.3 Asia Pacific 88 5.20.4 IMPACT ON END-USER INDUSTRIES 88 5.21 IMPACT OF ARTIFICIAL INTELLIGENCE ON OXYGEN CONCENTRATORS MARKET 88 5.22 ADJACENT MARKET ANALYSIS 89 6 OXYGEN CONCENTRATORS MARKET, BY TYPE 90 6.1 INTRODUCTION 91 6.2 PORTABLE OXYGEN CONCENTRATORS 91 6.3 STATIONARY OXYGEN CONCENTRATORS 93 7 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY 95 7.1 INTRODUCTION 96 7.2 CONTINUOUS FLOW 96 7.3 PULSE FLOW 97 8 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE 99 8.1 INTRODUCTION 100 8.2 0–5 L/MIN FLOWRATE 100 8.3 5–10 L/MIN FLOWRATE 101 8.4 ABOVE 10 L/MIN FLOWRATE 102 9 OXYGEN CONCENTRATORS MARKET, BY APPLICATION 104 9.1 INTRODUCTION 105 9.2 COPD 105 9.3 ASTHMA 106 9.4 RESPIRATORY DISTRESS 107 9.5 OTHER APPLICATIONS 108 10 OXYGEN CONCENTRATORS MARKET, BY END USER 110 10.1 INTRODUCTION 111 10.2 HOME CARE SETTINGS 111 10.3 HOSPITALS & CLINICS 112 10.4 AMBULATORY SURGICAL CENTERS & PHYSICIANS’ OFFICES 113 11 OXYGEN CONCENTRATORS MARKET, BY REGION 115 11.1 INTRODUCTION 116 11.2 NORTH AMERICA 116 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 117 11.2.2 US 120 11.2.2.1 Medicare coverage, COPD prevalence, and connected POCs to catalyze sustained market expansion through 2030 120 11.2.3 CANADA 122 11.2.3.1 Provincial funding, COPD burden, and connected POCs to accelerate home oxygen concentrator adoption trajectory 122 11.3 EUROPE 124 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 125 11.3.2 GERMANY 127 11.3.2.1 Strong payer coverage and clinical guidelines to drive predictable replacement cycles in Germany’s market 127 11.3.3 FRANCE 130 11.3.3.1 Hospital‑to‑home shift and connected devices sustain resilient replacement cycles in France’s oxygen concentrators market 130 11.3.4 UK 132 11.3.4.1 Aging population and funded home oxygen programs to underpin steady expansion 132 11.3.5 ITALY 134 11.3.5.1 Regional tenders, SSN homecare funding, and COPD burden to support steady growth in Italy’s market 134 11.3.6 SPAIN 137 11.3.6.1 Driving home-based healthcare with portable oxygen concentrator growth 137 11.3.7 REST OF EUROPE 139 11.4 ASIA PACIFIC 141 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 142 11.4.2 JAPAN 145 11.4.2.1 Stable funding and service‑led home care models to support steady growth 145 11.4.3 CHINA 148 11.4.3.1 Policy momentum and robust manufacturing ecosystem to drive resilient replacement cycles 148 11.4.4 INDIA 150 11.4.4.1 Building resilient healthcare infrastructure with rising oxygen concentrator demand 150 11.4.5 SOUTH KOREA 152 11.4.5.1 Hospital‑to‑home shift and connected POCs to propel South Korea’s portable and stationary oxygen concentrator demand growth 152 11.4.6 AUSTRALIA 155 11.4.6.1 Policy support, service networks, and digital monitoring to drive steady expansion of Australia’s market through 2030 155 11.4.7 REST OF ASIA PACIFIC 157 11.5 LATIN AMERICA 159 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 160 11.5.2 BRAZIL 162 11.5.2.1 Public procurement, ANVISA registration, and service networks to drive predictable replacement cycles in Brazil’s oxygen therapy landscape 162 11.5.3 MEXICO 164 11.5.3.1 Strengthening respiratory care access through expanding oxygen concentrator adoption 164 11.5.4 REST OF LATIN AMERICA 167 11.6 MIDDLE EAST & AFRICA 169 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 170 11.7 GCC COUNTRIES 172 11.7.1 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 172 12 COMPETITIVE LANDSCAPE 175 12.1 OVERVIEW 175 12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 175 12.3 REVENUE ANALYSIS 179 12.4 MARKET SHARE ANALYSIS 180 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 182 12.5.1 STARS 182 12.5.2 EMERGING LEADERS 182 12.5.3 PERVASIVE PLAYERS 182 12.5.4 PARTICIPANTS 182 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 184 12.5.5.1 Company footprint 184 12.5.5.2 Regional footprint 185 12.5.5.3 Type footprint 186 12.5.5.4 Application footprint 187 12.5.5.5 End User footprint 188 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 189 12.6.1 PROGRESSIVE COMPANIES 189 12.6.2 RESPONSIVE COMPANIES 189 12.6.3 DYNAMIC COMPANIES 189 12.6.4 STARTING BLOCKS 189 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 191 12.6.5.1 Detailed list of key startups/SMEs 191 12.6.5.2 Competitive benchmarking of startups/SMEs 192 12.7 COMPANY VALUATION AND FINANCIAL METRICS 193 12.7.1 FINANCIAL METRICS 193 12.7.2 COMPANY VALUATION 193 12.8 BRAND/PRODUCT COMPARISON 194 12.9 COMPETITIVE SCENARIO 195 12.9.1 PRODUCT LAUNCHES 195 12.9.2 DEALS 196 12.9.3 EXPANSIONS 197 13 COMPANY PROFILES 198 13.1 KEY PLAYERS 198 13.1.1 KONINKLIJKE PHILIPS N.V. 198 13.1.1.1 Business overview 198 13.1.1.2 Products offered 199 13.1.1.3 MnM view 200 13.1.1.3.1 Right to win 200 13.1.1.3.2 Strategic choices 200 13.1.1.3.3 Weaknesses and competitive threats 200 13.1.2 INOGEN, INC. 201 13.1.2.1 Business overview 201 13.1.2.2 Products offered 202 13.1.2.3 Recent developments 203 13.1.2.3.1 Product launches & approvals 203 13.1.2.3.2 Deals 203 13.1.2.4 MnM view 204 13.1.2.4.1 Right to win 204 13.1.2.4.2 Strategic choices 204 13.1.2.4.3 Weaknesses and competitive threats 204 13.1.3 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. 205 13.1.3.1 Business overview 205 13.1.3.2 Products offered 205 13.1.3.3 Recent developments 206 13.1.3.3.1 Deals 206 13.1.3.4 MnM view 206 13.1.3.4.1 Right to win 206 13.1.3.4.2 Strategic choices 206 13.1.3.4.3 Weaknesses and competitive threats 207 13.1.4 CAIRE INC. 208 13.1.4.1 Business overview 208 13.1.4.2 Products offered 208 13.1.4.3 Recent developments 209 13.1.4.3.1 Product launches & approvals 209 13.1.4.3.2 Deals 209 13.1.4.3.3 Expansions 209 13.1.4.4 MnM view 210 13.1.4.4.1 Right to win 210 13.1.4.4.2 Strategic choices 210 13.1.4.4.3 Weaknesses and competitive threats 210 13.1.5 DRIVE DEVILBISS HEALTHCARE 211 13.1.5.1 Business overview 211 13.1.5.2 Products offered 211 13.1.5.3 Recent developments 212 13.1.5.3.1 Product launches & approvals 212 13.1.5.4 MnM view 212 13.1.5.4.1 Right to win 212 13.1.5.4.2 Strategic choices 212 13.1.5.4.3 Weaknesses and competitive threats 212   13.1.6 TEIJIN LIMITED 213 13.1.6.1 Business overview 213 13.1.6.2 Products offered 214 13.1.7 DAIKIN INDUSTRIES, LTD. 215 13.1.7.1 Business overview 215 13.1.7.2 Products offered 216 13.1.8 ESAB CORPORATION (GCE GROUP) 217 13.1.8.1 Business overview 217 13.1.8.2 Products offered 218 13.1.9 REACT HEALTH 219 13.1.9.1 Business overview 219 13.1.9.2 Products offered 219 13.1.9.3 Recent developments 219 13.1.9.3.1 Deals 219 13.1.10 PRECISION MEDICAL, INC. 220 13.1.10.1 Business overview 220 13.1.10.2 Products offered 220 13.1.11 NIDEK MEDICAL PRODUCTS, INC. 221 13.1.11.1 Business overview 221 13.1.11.2 Products offered 221 13.1.12 O2 CONCEPTS, LLC 222 13.1.12.1 Business overview 222 13.1.12.2 Products offered 222 13.1.12.3 Recent developments 223 13.1.12.3.1 Product launches & approvals 223 13.1.12.3.2 Deals 223 13.1.13 BPL MEDICAL TECHNOLOGIES 224 13.1.13.1 Business overview 224 13.1.13.2 Products offered 224 13.1.14 BESCO 225 13.1.14.1 Business overview 225 13.1.14.2 Products offered 225 13.1.15 OXUS 226 13.1.15.1 Business overview 226 13.1.15.2 Products offered 226 13.2 OTHER COMPANIES 227 13.2.1 FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO., LTD 227 13.2.2 LONGFIAN SCITECH CO., LTD. 228 13.2.3 SHENYANG CANTA MEDICAL TECH. CO., LTD. 229 13.2.4 BELLUSCURA 230 13.2.5 HOYO SCITECH CO., LTD. 231 13.2.6 HACENOR SOLUTIONS 232 13.2.7 XNUO INTERNATIONAL GROUP (USA) HOLDINGS 232 13.2.8 OXYMED 233 13.2.9 KALSTEIN 234 13.2.10 ESS PEE ENTERPRISES 235 14 APPENDIX 236 14.1 DISCUSSION GUIDE 236 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 242 14.3 CUSTOMIZATION OPTIONS 244 14.4 RELATED REPORTS 244 14.5 AUTHOR DETAILS 245
圖表清單 List of Tables & Figures
TABLE 1 USD STANDARD CURRENCY CONVERSION RATES, 2020–2024 27 TABLE 2 RISK ASSESSMENT: OXYGEN CONCENTRATORS 43 TABLE 3 OXYGEN CONCENTRATORS MARKET: IMPACT OF ANALYSIS OF MARKET DYNAMICS 53 TABLE 4 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD) 59 TABLE 5 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2022–2024 (USD) 60 TABLE 6 OXYGEN CONCENTRATORS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 64 TABLE 7 IMPORT DATA FOR HS CODE 901920-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 71 TABLE 8 EXPORT DATA FOR HS CODE 901920-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 72 TABLE 9 OXYGEN CONCENTRATORS MARKET: KEY CONFERENCES & EVENTS, 2025–2026 73 TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75 TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 14 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76 TABLE 15 OXYGEN CONCENTRATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 82 TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO PRODUCTS 83 TABLE 17 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS 84 TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024 86 TABLE 19 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR OXYGEN CONCENTRATORS 87 TABLE 20 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 91 TABLE 21 EXAMPLES OF PORTABLE OXYGEN CONCENTRATORS (POC) 91 TABLE 22 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 92 TABLE 23 PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2023–2030 (UNITS) 92 TABLE 24 EXAMPLES OF STATIONARY OXYGEN CONCENTRATORS (POC) 93 TABLE 25 STATIONARY OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 94 TABLE 26 STATIONARY OXYGEN CONCENTRATORS MARKET, BY REGION, 2023–2030 (UNITS) 94 TABLE 27 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 96 TABLE 28 CONTINUOUS-FLOW OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 97 TABLE 29 PULSE-FLOW OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 30 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 100 TABLE 31 0–5 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 32 5–10 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 33 ABOVE 10 L/MIN FLOWRATE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 34 OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 105 TABLE 35 OXYGEN CONCENTRATORS MARKET FOR COPD, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 36 OXYGEN CONCENTRATORS MARKET FOR ASTHMA, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 37 OXYGEN CONCENTRATORS MARKET FOR RESPIRATORY DISTRESS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 38 OXYGEN CONCENTRATORS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 39 OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 111 TABLE 40 OXYGEN CONCENTRATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 41 OXYGEN CONCENTRATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 42 OXYGEN CONCENTRATORS MARKET FOR AMBULATORY SURGICAL CENTERS & PHYSICIANS’ OFFICES, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 43 OXYGEN CONCENTRATORS MARKET, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 44 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 45 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 118 TABLE 46 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 118 TABLE 47 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 119 TABLE 48 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 119 TABLE 49 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 119 TABLE 50 US: MACROECONOMIC INDICATORS 120 TABLE 51 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 120 TABLE 52 US: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 121 TABLE 53 US: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 121 TABLE 54 US: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 121 TABLE 55 US: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 122 TABLE 56 CANADA: MACROECONOMIC INDICATORS 122 TABLE 57 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 123 TABLE 58 CANADA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 123 TABLE 59 CANADA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 123 TABLE 60 CANADA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 124 TABLE 61 CANADA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 124 TABLE 62 EUROPE: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 63 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 126 TABLE 64 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 126 TABLE 65 EUROPE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 126 TABLE 66 EUROPE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 127 TABLE 67 EUROPE: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 127 TABLE 68 GERMANY: MACROECONOMIC INDICATORS 128 TABLE 69 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 128 TABLE 70 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 128 TABLE 71 GERMANY: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 129 TABLE 72 GERMANY: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 129 TABLE 73 GERMANY: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 74 FRANCE: MACROECONOMIC INDICATORS 130 TABLE 75 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 76 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 131 TABLE 77 FRANCE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 131 TABLE 78 FRANCE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 79 FRANCE: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 132 TABLE 80 UK: MACROECONOMIC INDICATORS 133 TABLE 81 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 82 UK: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 133 TABLE 83 UK: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 133 TABLE 84 UK: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134 TABLE 85 UK: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 134 TABLE 86 ITALY: MACROECONOMIC INDICATORS 135 TABLE 87 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135 TABLE 88 ITALY: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 135 TABLE 89 ITALY: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 136 TABLE 90 ITALY: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 136 TABLE 91 ITALY: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 136 TABLE 92 SPAIN: MACROECONOMIC INDICATORS 137 TABLE 93 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 94 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 138 TABLE 95 SPAIN: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 138 TABLE 96 SPAIN: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 138 TABLE 97 SPAIN: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 139 TABLE 98 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 140 TABLE 99 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 140 TABLE 100 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 140 TABLE 101 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 141 TABLE 102 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 141 TABLE 103 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 104 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 105 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 144 TABLE 106 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 144 TABLE 107 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 145 TABLE 108 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 145 TABLE 109 JAPAN: MACROECONOMIC INDICATORS 146 TABLE 110 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 146 TABLE 111 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 146 TABLE 112 JAPAN: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 147 TABLE 113 JAPAN: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 147 TABLE 114 JAPAN: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 147 TABLE 115 CHINA: MACROECONOMIC INDICATORS 148 TABLE 116 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 148 TABLE 117 CHINA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 149 TABLE 118 CHINA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 149 TABLE 119 CHINA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 149 TABLE 120 CHINA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 121 INDIA: MACROECONOMIC INDICATORS 150 TABLE 122 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 123 INDIA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 151 TABLE 124 INDIA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 151 TABLE 125 INDIA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 152 TABLE 126 INDIA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 152 TABLE 127 SOUTH KOREA: MACROECONOMIC INDICATORS 153 TABLE 128 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 129 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 153 TABLE 130 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 154 TABLE 131 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 154 TABLE 132 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 133 AUSTRALIA: MACROECONOMIC INDICATORS 155 TABLE 134 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 155 TABLE 135 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 156 TABLE 136 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 156 TABLE 137 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 156 TABLE 138 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 139 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 158 TABLE 140 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 158 TABLE 141 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 158 TABLE 142 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 159 TABLE 143 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 159 TABLE 144 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 145 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 160 TABLE 146 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 161 TABLE 147 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 161 TABLE 148 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 161 TABLE 149 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 162 TABLE 150 BRAZIL: MACROECONOMIC INDICATORS 163 TABLE 151 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 152 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 163 TABLE 153 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 163 TABLE 154 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 164 TABLE 155 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 164 TABLE 156 MEXICO: MACROECONOMIC INDICATORS 165 TABLE 157 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 158 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 165 TABLE 159 MEXICO: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 166 TABLE 160 MEXICO: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166 TABLE 161 MEXICO: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 162 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 163 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 168 TABLE 164 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 168 TABLE 165 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168 TABLE 166 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 169 TABLE 167 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 168 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 170 TABLE 169 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 171 TABLE 170 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171 TABLE 171 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 172 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 173 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 173 TABLE 174 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2023–2030 (USD MILLION) 173 TABLE 175 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 174 TABLE 176 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY END USER, 2023–2030 (USD MILLION) 174 TABLE 177 KEY DEVELOPMENTS IN OXYGEN CONCENTRATORS MARKET, JANUARY 2021–JULY 2025 176 TABLE 178 OXYGEN CONCENTRATORS MARKET: DEGREE OF COMPETITION 180 TABLE 179 OXYGEN CONCENTRATORS MARKET: REGIONAL FOOTPRINT, 2024 185 TABLE 180 OXYGEN CONCENTRATORS MARKET: TYPE FOOTPRINT, 2024 186 TABLE 181 OXYGEN CONCENTRATORS MARKET: APPLICATION FOOTPRINT, 2024 187 TABLE 182 OXYGEN CONCENTRATORS MARKET: END USER FOOTPRINT, 2024 188 TABLE 183 OXYGEN CONCENTRATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 191 TABLE 184 OXYGEN CONCENTRATORS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2024 192 TABLE 185 OXYGEN CONCENTRATORS MARKET: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 195 TABLE 186 OXYGEN CONCENTRATORS MARKET: DEALS, JANUARY 2021–JULY 2025 196 TABLE 187 OXYGEN CONCENTRATORS MARKET: EXPANSIONS, JANUARY 2021–JULY 2025 197 TABLE 188 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 198 TABLE 189 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 199 TABLE 190 INOGEN, INC.: COMPANY OVERVIEW 201 TABLE 191 INOGEN, INC.: PRODUCTS OFFERED 202 TABLE 192 INOGEN, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JULY 2025 203 TABLE 193 INOGEN INC.: DEALS 203 TABLE 194 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.: COMPANY OVERVIEW 205 TABLE 195 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.: PRODUCTS OFFERED 205 TABLE 196 JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD..: DEALS 206 TABLE 197 CAIRE INC.: COMPANY OVERVIEW 208 TABLE 198 CAIRE INC.: PRODUCTS OFFERED 208 TABLE 199 CAIRE INC.: PRODUCT LAUNCHES & APPROVALS 209 TABLE 200 CAIRE INC.: DEALS 209 TABLE 201 CAIRE INC.: EXPANSIONS 209 TABLE 202 DRIVE DEVILBISS HEALTHCARE: COMPANY OVERVIEW 211 TABLE 203 DRIVE DEVILBISS HEALTHCARE: PRODUCTS OFFERED 211 TABLE 204 DRIVE DEVILBISS HEALTHCARE: PRODUCT LAUNCHES & APPROVALS 212 TABLE 205 TEIJIN LIMITED: COMPANY OVERVIEW 213 TABLE 206 TEIJIN LIMITED: PRODUCTS OFFERED 214 TABLE 207 DAIKIN INDUSTRIES, LTD.: COMPANY OVERVIEW 215 TABLE 208 DAIKIN INDUSTRIES, LTD.: PRODUCTS OFFERED 216 TABLE 209 ESAB CORPORATION (GCE GROUP): COMPANY OVERVIEW 217 TABLE 210 ESAB CORPORATION (GCE GROUP): PRODUCTS OFFERED 218 TABLE 211 REACT HEALTH: COMPANY OVERVIEW 219 TABLE 212 REACT HEALTH: PRODUCTS OFFERED 219 TABLE 213 REACT HEALTH.: DEALS, JANUARY 2021–JULY 2025 219 TABLE 214 PRECISION MEDICAL, INC.: COMPANY OVERVIEW 220 TABLE 215 PRECISION MEDICAL, INC.: PRODUCTS OFFERED 220 TABLE 216 NIDEK MEDICAL PRODUCTS, INC.: COMPANY OVERVIEW 221 TABLE 217 NIDEK MEDICAL PRODUCTS, INC.: PRODUCTS OFFERED 221 TABLE 218 O2 CONCEPTS, LLC: COMPANY OVERVIEW 222 TABLE 219 O2 CONCEPTS, LLC: PRODUCTS OFFERED 222 TABLE 220 O2 CONCEPTS, LLC: PRODUCT LAUNCHES & APPROVALS 223 TABLE 221 O2 CONCEPTS, LLC: DEALS 223 TABLE 222 BPL MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 224 TABLE 223 BPL MEDICAL TECHNOLOGIES: PRODUCTS OFFERED 224 TABLE 224 BESCO: COMPANY OVERVIEW 225 TABLE 225 BESCO: PRODUCTS OFFERED 225 TABLE 226 OXUS: COMPANY OVERVIEW 226 TABLE 227 OXUS: PRODUCTS OFFERED 226 TABLE 228 FOSHAN KEYHUB ELECTRONIC INDUSTRIES CO., LTD: COMPANY OVERVIEW 227 TABLE 229 LONGFIAN SCITECH CO., LTD.: COMPANY OVERVIEW 228 TABLE 230 SHENYANG CANTA MEDICAL TECH. CO., LTD.: COMPANY OVERVIEW 229 TABLE 231 BELLUSCURA: COMPANY OVERVIEW 230 TABLE 232 HOYO SCITECH CO., LTD.: COMPANY OVERVIEW 231 TABLE 233 HACENOR SOLUTIONS: COMPANY OVERVIEW 232 TABLE 234 XNUO INTERNATIONAL GROUP (USA) HOLDINGS: COMPANY OVERVIEW 232 TABLE 235 OXYMED: COMPANY OVERVIEW 233 TABLE 236 KALSTEIN: COMPANY OVERVIEW 234 TABLE 237 ESS PEE ENTERPRISES: COMPANY OVERVIEW 235 FIGURE 1 OXYGEN CONCENTRATORS MARKET SEGMENTATION 26 FIGURE 2 RESEARCH DESIGN 29 FIGURE 3 KEY DATA FROM SECONDARY RESEARCH 31 FIGURE 4 PRIMARY SOURCES 31 FIGURE 5 KEY DATA FROM PRIMARY SOURCES 32 FIGURE 6 KEY INSIGHTS FROM INDUSTRY EXPERTS 33 FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION 34 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY END USER, DESIGNATION, AND REGION 34 FIGURE 10 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 35 FIGURE 11 REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. 36 FIGURE 12 SUPPLY-SIDE MARKET SIZE ESTIMATION: OXYGEN CONCENTRATORS, 2024 37 FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES, 2025–2030 38 FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39 FIGURE 15 TOP-DOWN APPROACH 39 FIGURE 16 DATA TRIANGULATION METHODOLOGY 41 FIGURE 17 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 44 FIGURE 18 OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 45 FIGURE 19 OXYGEN CONCENTRATORS MARKET, BY FLOWRATE, 2025 VS. 2030 (USD MILLION) 45 FIGURE 20 OXYGEN CONCENTRATORS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 46 FIGURE 21 OXYGEN CONCENTRATORS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 46 FIGURE 22 GEOGRAPHICAL SNAPSHOT OF OXYGEN CONCENTRATORS MARKET 47 FIGURE 23 RISING INVESTMENTS IN HEALTHCARE, DEMAND FOR INTEGRATED MULTIFUNCTIONAL DEVICES, AND EXPANDING ACCESS TO ADVANCED ICUS IN UNDERSERVED REGIONS TO DRIVE MARKET GROWTH 48 FIGURE 24 JAPAN AND PORTABLE OXYGEN CONCENTRATORS ACCOUNTED FOR LARGEST RESPECTIVE SHARES IN ASIA PACIFIC IN 2024 49 FIGURE 25 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 50 FIGURE 26 NORTH AMERICA TO DOMINATE OXYGEN CONCENTRATORS MARKET 50 FIGURE 27 EMERGING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 51 FIGURE 28 OXYGEN CONCENTRATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52 FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 58 FIGURE 30 AVERAGE SELLING PRICE TREND OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2022–2024 (USD) 60 FIGURE 31 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND DISTRIBUTION PHASES 61 FIGURE 32 OXYGEN CONCENTRATORS MARKET: SUPPLY CHAIN ANALYSIS 63 FIGURE 33 OXYGEN CONCENTRATORS MARKET: ECOSYSTEM ANALYSIS 64 FIGURE 34 OXYGEN CONCENTRATORS MARKET: INVESTMENT & FUNDING SCENARIO, 2019–2023 66 FIGURE 35 OXYGEN CONCENTRATORS MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 66 FIGURE 36 OXYGEN CONCENTRATORS MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 67 FIGURE 37 OXYGEN CONCENTRATORS MARKET: PATENT ANALYSIS, JANUARY 2015−JULY 2025 70 FIGURE 38 OXYGEN CONCENTRATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 81 FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP TWO PRODUCTS 83 FIGURE 40 KEY BUYING CRITERIA FOR TOP TWO PRODUCTS 84 FIGURE 41 OXYGEN CONCENTRATORS MARKET: IMPACT OF AI/GEN AI 89 FIGURE 42 OXYGEN CONCENTRATORS MARKET: ADJACENT MARKETS 89 FIGURE 43 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET SNAPSHOT 117 FIGURE 44 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET SNAPSHOT 143 FIGURE 45 REVENUE ANALYSIS OF TOP PLAYERS IN OXYGEN CONCENTRATORS MARKET, 2020–2024 (USD MILLION) 179 FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 180 FIGURE 47 OXYGEN CONCENTRATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 183 FIGURE 48 OXYGEN CONCENTRATORS MARKET: COMPANY FOOTPRINT, 2024 184 FIGURE 49 OXYGEN CONCENTRATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 190 FIGURE 50 EV/EBITDA OF KEY VENDORS, 2025 193 FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 193 FIGURE 52 OXYGEN CONCENTRATORS MARKET: BRAND/PRODUCT COMPARISON 194 FIGURE 53 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 199 FIGURE 54 INOGEN, INC.: COMPANY SNAPSHOT 202 FIGURE 55 TEIJIN LIMITED: COMPANY SNAPSHOT 214 FIGURE 56 DAIKIN INDUSTRIES, LTD.: COMPANY SNAPSHOT 216 FIGURE 57 ESAB CORPORATION (GCE GROUP): COMPANY SNAPSHOT 218

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們